Milrinone on Right Ventricular Strain in Cardiac Surgery

Launched by KONKUK UNIVERSITY MEDICAL CENTER · Oct 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a medication called milrinone affects the right side of the heart in patients having heart surgery. Specifically, the researchers want to see if milrinone can help improve how well the right ventricle (the chamber of the heart that pumps blood to the lungs) works after surgery. The trial is open to both men and women over the age of 18 who are scheduled for elective heart surgery and have a certain level of heart function before the procedure.

To participate, patients need to agree to be part of the study and provide written consent. They should have a good level of heart function before surgery (with a measurement called left ventricular ejection fraction above 50%), but they cannot have certain conditions like irregular heartbeats or be on other heart medications at the same time. Participants in the trial will receive milrinone and undergo tests to measure how their heart is functioning before and after the medication is given. This study aims to find out if milrinone can make a difference in heart performance during recovery from surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patient agree and provide written informed consent.
• • patient undergoing elective cardiac surgery
• • preoperative LV EF\>50% (TTE)
• Exclusion Criteria:
• • preoperative cardiac dysrhythmia
• • preoperative IABP
• • use of other inotropic agents